152 related articles for article (PubMed ID: 11064451)
1. CL100/MKP-1 modulates JNK activation and apoptosis in response to cisplatin.
Sánchez-Pérez I; Martínez-Gomariz M; Williams D; Keyse SM; Perona R
Oncogene; 2000 Oct; 19(45):5142-52. PubMed ID: 11064451
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase.
Groom LA; Sneddon AA; Alessi DR; Dowd S; Keyse SM
EMBO J; 1996 Jul; 15(14):3621-32. PubMed ID: 8670865
[TBL] [Abstract][Full Text] [Related]
3. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients.
Vicent S; Garayoa M; López-Picazo JM; Lozano MD; Toledo G; Thunnissen FB; Manzano RG; Montuenga LM
Clin Cancer Res; 2004 Jun; 10(11):3639-49. PubMed ID: 15173070
[TBL] [Abstract][Full Text] [Related]
4. The role of mitogen-activated protein kinase phosphatase-1 in oxidative damage-induced cell death.
Zhou JY; Liu Y; Wu GS
Cancer Res; 2006 May; 66(9):4888-94. PubMed ID: 16651445
[TBL] [Abstract][Full Text] [Related]
5. Cellular defense against H2O2-induced apoptosis via MAP kinase-MKP-1 pathway.
Xu Q; Konta T; Nakayama K; Furusu A; Moreno-Manzano V; Lucio-Cazana J; Ishikawa Y; Fine LG; Yao J; Kitamura M
Free Radic Biol Med; 2004 Apr; 36(8):985-93. PubMed ID: 15059639
[TBL] [Abstract][Full Text] [Related]
6. Mitogen-activated protein kinase phosphatase-1 is a mediator of breast cancer chemoresistance.
Small GW; Shi YY; Higgins LS; Orlowski RZ
Cancer Res; 2007 May; 67(9):4459-66. PubMed ID: 17483361
[TBL] [Abstract][Full Text] [Related]
7. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells.
Chen TH; Kao YC; Chen BC; Chen CH; Chan P; Lee HM
Eur J Pharmacol; 2006 Jul; 541(3):138-46. PubMed ID: 16765938
[TBL] [Abstract][Full Text] [Related]
8. Evidence that mitogen-activated protein kinase phosphatase-1 induction by proteasome inhibitors plays an antiapoptotic role.
Small GW; Shi YY; Edmund NA; Somasundaram S; Moore DT; Orlowski RZ
Mol Pharmacol; 2004 Dec; 66(6):1478-90. PubMed ID: 15448190
[TBL] [Abstract][Full Text] [Related]
9. Aplidin induces JNK-dependent apoptosis in human breast cancer cells via alteration of glutathione homeostasis, Rac1 GTPase activation, and MKP-1 phosphatase downregulation.
González-Santiago L; Suárez Y; Zarich N; Muñoz-Alonso MJ; Cuadrado A; Martínez T; Goya L; Iradi A; Sáez-Tormo G; Maier JV; Moorthy A; Cato AC; Rojas JM; Muñoz A
Cell Death Differ; 2006 Nov; 13(11):1968-81. PubMed ID: 16543941
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase Cdelta-mediated proteasomal degradation of MAP kinase phosphatase-1 contributes to glutamate-induced neuronal cell death.
Choi BH; Hur EM; Lee JH; Jun DJ; Kim KT
J Cell Sci; 2006 Apr; 119(Pt 7):1329-40. PubMed ID: 16537649
[TBL] [Abstract][Full Text] [Related]
11. Proteasome inhibitors induce a p38 mitogen-activated protein kinase (MAPK)-dependent anti-apoptotic program involving MAPK phosphatase-1 and Akt in models of breast cancer.
Shi YY; Small GW; Orlowski RZ
Breast Cancer Res Treat; 2006 Nov; 100(1):33-47. PubMed ID: 16807678
[TBL] [Abstract][Full Text] [Related]
12. DNA damage in transcribed genes induces apoptosis via the JNK pathway and the JNK-phosphatase MKP-1.
Hamdi M; Kool J; Cornelissen-Steijger P; Carlotti F; Popeijus HE; van der Burgt C; Janssen JM; Yasui A; Hoeben RC; Terleth C; Mullenders LH; van Dam H
Oncogene; 2005 Nov; 24(48):7135-44. PubMed ID: 16044158
[TBL] [Abstract][Full Text] [Related]
13. Compartment-specific regulation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) mitogen-activated protein kinases (MAPKs) by ERK-dependent and non-ERK-dependent inductions of MAPK phosphatase (MKP)-3 and MKP-1 in differentiating P19 cells.
Reffas S; Schlegel W
Biochem J; 2000 Dec; 352 Pt 3(Pt 3):701-8. PubMed ID: 11104676
[TBL] [Abstract][Full Text] [Related]
14. Atrial natriuretic peptide induces mitogen-activated protein kinase phosphatase-1 in human endothelial cells via Rac1 and NAD(P)H oxidase/Nox2-activation.
Fürst R; Brueckl C; Kuebler WM; Zahler S; Krötz F; Görlach A; Vollmar AM; Kiemer AK
Circ Res; 2005 Jan; 96(1):43-53. PubMed ID: 15569826
[TBL] [Abstract][Full Text] [Related]
15. MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer.
Chattopadhyay S; Machado-Pinilla R; Manguan-García C; Belda-Iniesta C; Moratilla C; Cejas P; Fresno-Vara JA; de Castro-Carpeño J; Casado E; Nistal M; Gonzalez-Barón M; Perona R
Oncogene; 2006 Jun; 25(23):3335-45. PubMed ID: 16462770
[TBL] [Abstract][Full Text] [Related]
16. Triptolide suppresses interleukin-1beta-induced human beta-defensin-2 mRNA expression through inhibition of transcriptional activation of NF-kappaB in A549 cells.
Jang BC; Lim KJ; Choi IH; Suh MH; Park JG; Mun KC; Bae JH; Shin DH; Suh SI
Int J Mol Med; 2007 May; 19(5):757-63. PubMed ID: 17390080
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid inhibits hepatic Jun N-terminal kinase-dependent signaling pathway in ethanol-fed rats.
Chung J; Chavez PR; Russell RM; Wang XD
Oncogene; 2002 Feb; 21(10):1539-47. PubMed ID: 11896582
[TBL] [Abstract][Full Text] [Related]
18. Osmotic regulation of insulin-induced mitogen-activated protein kinase phosphatase (MKP-1) expression in H4IIE rat hepatoma cells.
Lornejad-Schäfer MR; Schäfer C; Graf D; Häussinger D; Schliess F
Biochem J; 2003 Apr; 371(Pt 2):609-19. PubMed ID: 12529177
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin induces a persistent activation of JNK that is related to cell death.
Sánchez-Perez I; Murguía JR; Perona R
Oncogene; 1998 Jan; 16(4):533-40. PubMed ID: 9484843
[TBL] [Abstract][Full Text] [Related]
20. Regulation of c-Jun N-terminal kinase and p38 kinase pathways in endothelial cells.
Wadgaonkar R; Pierce JW; Somnay K; Damico RL; Crow MT; Collins T; Garcia JG
Am J Respir Cell Mol Biol; 2004 Oct; 31(4):423-31. PubMed ID: 15231489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]